Case Study

Ensuring Quality & Compliance in Global Pharma Trade In the highly regulated world of B2B cross-border pharma trade, ensuring the quality, safety, and efficacy of pharmaceutical products is crucial. One of the most important documents that helps achieve this is the Certificate of Analysis (CoA). This document is essential for pharmaceutical bulk buyers, pharma distributors,

Key Takeaways Africa holds 94% of global malaria cases and 95% of deaths. Demand for antimalarial drugs is rising due to resistance and population growth. ACT resistance is spreading in East Africa, reducing drug effectiveness. Urbanization and youth demographics increase malaria exposure. Pharmint supports access through quality manufacturing and delivery. Africa continues to bear the

In cross-border B2B pharma trade, ensuring quality assurance is essential for the safety, efficacy, and regulatory compliance of medicines and medical supplies. International buyers face multiple challenges, from verifying supplier credibility to ensuring products meet stringent WHO-GMP, US FDA, and EU GMP standards. Pharmint, a leading B2B pharma marketplace in India, simplifies this process by

India has emerged as the global leader in contract manufacturing for the pharmaceutical industry, supplying high-quality, cost-effective medicines to regulated and semi-regulated markets worldwide. With increasing demand from Africa, Europe, Latin America, and the Middle East, contract manufacturing is fueling India’s dominance in B2B cross-border pharma trade. Leading B2B pharma marketplaces in India, like Pharmint,

The pharmaceutical industry is witnessing a massive shift, with digital transformation revolutionizing pharma wholesale distribution worldwide. Traditional medicine B2B wholesale India online models relied heavily on manual transactions, intermediaries, and outdated processes. Today, with B2B online wholesale medicine supply for pharmacy, buyers and sellers are experiencing faster, more transparent, and cost-effective trade solutions. Leading online

Why Biosimilars are Transforming the Global Pharmaceutical Market The biosimilars industry is experiencing rapid growth as healthcare systems worldwide seek cost-effective alternatives to expensive biologic drugs. With patent expirations of blockbuster biologics, the global demand for biosimilars is soaring, particularly in oncology, autoimmune diseases, diabetes, and cardiovascular conditions. For B2B pharma buyers, sourcing high-quality biosimilars

Pharmint: Simplifying Global Sourcing for Radiopharmaceuticals Radiopharmaceuticals, or radioactive drugs used for diagnosis and treatment, are experiencing significant global demand due to advancements in medical imaging and targeted therapies. With the rise of cancer treatments, nuclear medicine, and PET-CT scans, the need for high-quality radiopharmaceuticals is growing worldwide. As B2B pharma buyers, hospitals, and research

The global pharmaceutical trade is a highly complex industry, with fluctuating prices, hidden costs, and multiple intermediaries affecting the final price of medicines. For international buyers, especially those sourcing from B2B pharma marketplaces in India, price transparency is crucial for making informed purchasing decisions, avoiding overpricing, and improving cost efficiency. At Pharmint, we understand that